FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacology, and represents an agent compensating calcium deficiency, containing gum arabic as an active substance characterised by the fact that said gum arabic is taken in amount 1-100 g/day.
EFFECT: invention provides higher effectiveness of calcium absorption.
12 cl, 3 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| FOOD CALCIUM-CONTAINING SUPPLEMENT AND FUNCTIONAL FOODSTUFF CONTAINING THE SAME | 2004 |
|
RU2270586C2 |
| VEGETABLE EXTRACTS FOR TREATMENT OF ENHANCED BONE RESORPTION | 1998 |
|
RU2196601C2 |
| APPLICATION OF HESPERIDINE OR ONE OF ITS DERIVATIVES FOR MANUFACTURING MEDICINAL PREPARATION INDICATED FOR OSTEOGENESIS STIMULATION | 2003 |
|
RU2320346C2 |
| METHOD FOR PREVENTION OF TOXIC ACTION OF CADMIUM IN EXPERIMENTAL ANIMALS SUFFERING CHRONIC POISONING | 2011 |
|
RU2462763C1 |
| PROLONGED SLOW RELEASE PHARMACEUTICAL COMPOSITION CONTAINING WATER SUSPENSION OF BISPHOSPHONATE | 2007 |
|
RU2453316C2 |
| PROBIOTIC STRAINS FOR APPLICATION IN OSTEOPOROSIS TREATMENT OR PREVENTION | 2014 |
|
RU2636027C2 |
| METHOD FOR RELIEVING LEAD ACETATE NEPHROTOXICITY | 2010 |
|
RU2461072C2 |
| METHOD OF REHABILITATION OF CHILDREN AND TEENAGERS WITH FRACTURES IN COMBINATION OF OSTEOPENIC SYNDROME | 2008 |
|
RU2391087C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENOPAUSE OSTEOPOROSIS IN WOMEN | 2007 |
|
RU2379043C2 |
| METHOD OF REDUCING NEPHROTOXICITY OF AMMONIUM MOLYBDATE | 2015 |
|
RU2588319C1 |
